Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.
D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004381:Duodenal Ulcer / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D005750:Gastric Juice / Q000378:metabolism*; D005755:Gastrins / Q000097:blood; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010461:Peptones / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects; D013440:Sulfides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013890:Thiourea / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use
D005755:Gastrins; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D010461:Peptones; D011955:Receptors, Drug; D013440:Sulfides; D013890:Thiourea